Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11 C-Labeled Radioligands That Avoid Radiometabolite Contamination
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Meijuan Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Carbon Radioisotopes, Cyclic Nucleotide Phosphodiesterases, Type 4, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Phosphodiesterase-4D (PDE4D) has emerged as a significant target for treating neuropsychiatric disorders, but no PET radioligand currently exists for robustly quantifying human brain PDE4D to assist biomedical research and drug discovery. A prior candidate PDE4D PET radioligand, namely [11C]T1650, failed in humans because of poor time stability of brain PDE4D-specific signal (indexed by total volume of distribution), likely due to radiometabolites accumulating in brain. Its nitro group was considered to be a source of the brain radiometabolites.
Methods
We selected 5 high-affinity and selective PDE4D inhibitors, absent of a nitro group, from our prior structure-activity relationship study for evaluation as PET radioligands.
Results
All 5 radioligands were labeled with 11C (half-time, 20.4 min) in useful yields and with high molar activity. All displayed sizable PDE4D-specific signals in rhesus monkey brain. Notably, [11C]JMJ-81 and [11C]JMJ-129 exhibited excellent time stability of signal (total volume of distribution). Furthermore, as an example, [11C]JMJ-81 was found to be free of radiometabolites in ex vivo monkey brain, affirming that this radioligand can provide robust quantification of brain PDE4D with PET.
Conclusion
Given their high similarity in structures and metabolic profiles, both [11C]JMJ-81 and [11C]JMJ-129 warrant further evaluation in human subjects. [11C]JMJ-129 shows a higher PDE4D specific-to-nonspecific binding ratio and will be the first to be evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
- Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland pikev@mail.nih.gov sanjay.telu@nih.gov.
Förderung
- Intramural NIH HHS
Zitieren
APA
Jiang, M., Tang, S., Jenkins, M. D., Lee, A. C., Kenou, B., Knoer, C., Montero Santamaria, J., Wu, S., Liow, J. S., Zoghbi, S. S., Zanotti-Fregonara, P., Innis, R. B., Telu, S., & Pike, V. W. (2024). Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11 C-Labeled Radioligands That Avoid Radiometabolite Contamination. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266750
Vancouver
Jiang M, Tang S, Jenkins MD, Lee AC, Kenou B, Knoer C, et al. Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11 C-Labeled Radioligands That Avoid Radiometabolite Contamination. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266750
BibTeX
@article{Jiang2024,
author = {Jiang, Meijuan and Tang, Shiyu and Jenkins, Madeline D and Lee, Adrian C and Kenou, Bruny and Knoer, Carson and Montero Santamaria, Jose and Wu, Shawn and Liow, Jeih-San and Zoghbi, Sami S and Zanotti-Fregonara, Paolo and Innis, Robert B and Telu, Sanjay and Pike, Victor W},
title = {Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11 C-Labeled Radioligands That Avoid Radiometabolite Contamination},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266750}
}
EUVIMED